Tradestie Institutional Equity Comparison Engine

VCYT vs CGEN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CGEN Overall Edge

CGEN Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Compugen Ltd (CGEN) driven by superior Valuation, Growth & Margin, Momentum & Technical while VCYT counters with relative strength in Options & Structure. Fundamentally, VCYT trades at 15.5x Forward P/E with 15.0% operating margin (+15.1% YoY revenue) versus CGEN at 12.4x Forward P/E and 41.3% operating margin (+102.1% YoY). In options structure, VCYT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against CGEN sits in BREAKDOWN (57th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CGEN
VCYT 15.5x vs CGEN 12.4x Fwd P/E
Growth & Margin Winner CGEN
Op Margin 15.0% vs 41.3% ยท YoY +15.1% vs +102.1%
Momentum & Technical Winner CGEN
1Y -38.4% vs +23.2% ยท 52W Pos 6% vs 33%
Options & Structure Winner VCYT
BREAKDOWN (9th %ile IV) vs BREAKDOWN (57th %ile IV)
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.23
+0.92% 1D
Market Cap $1.9B
1M Return -44.68%
1Y Return -38.42%
Forward P/E 15.5x
Unified AI Score
48.0 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0
CGEN NASDAQ
Compugen Ltd
Biological Products, (No Diagnostic Substances)
$2.02
-0.98% 1D
Market Cap $193.2M
1M Return +2.54%
1Y Return +23.17%
Forward P/E 12.4x
Unified AI Score
47.1 / 100 HOLD
Tech 44.0 Fund 52.0 Flow 54.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VCYT -38.42% CGEN +23.17% Spread: +61.59 pp (CGEN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VCYT Revenue CGEN Revenue VCYT Op. Margin CGEN Op. Margin Margin Edge
FY2018 $90M $20M -24.2% -130.5% VCYT
FY2019 $120M N/A -12.6% N/A VCYT
FY2020 $120M $0M -30.1% -1574.8% VCYT
FY2021 $220M $10M -37.3% -584.6% VCYT
FY2022 $300M $10M -13.9% -471.7% VCYT
FY2023 $360M $30M -23.8% -38.8% VCYT
FY2024 $450M $30M 3.6% -53.4% VCYT
FY2025 $520M $70M 11.2% 43.1% CGEN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VCYT (2) vs CGEN (8)
Institutional Metric VCYT CGEN Criterion Row Winner
Market Capitalization Scale $1.9B $193.2M Larger Scale VCYT
Trailing P/E Ratio Valuation 15.6x 5.2x Lower Multiple CGEN
Forward P/E Ratio Valuation 15.5x 12.4x Lower Multiple CGEN
Revenue Growth (YoY) Growth +15.1% +102.1% Higher Growth CGEN
Operating Margin (TTM) Profitability 15.0% 41.3% Higher Margin CGEN
Net Profit Margin Profitability 21.8% 47.9% Higher Margin CGEN
Return on Equity (ROE) Capital Efficiency 9.4% 57.2% Higher ROE CGEN
52-Week Range Position Momentum 6% ($22โ€“$61) 33% ($1โ€“$3) Stronger Trend CGEN
Beta / 30D Volatility Risk Regime 2.98ฮฒ ยท 194% Vol 1.44ฮฒ ยท 62% Vol Lower Realized Risk CGEN
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 47.1 / 100 (HOLD) Higher Composite VCYT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VCYT vs CGEN Buy Guide
VCYT BREAKDOWN
100d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CGEN BREAKDOWN
143d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 57th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VCYT nor CGEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.